1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Regional Analysis
6.2 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Revenue 2019-2028 (US$ Thousand)
6.3 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Forecast Analysis
7. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis – by Diagnosis
7.1 Breath Testing
- 7.1.1 Overview
- 7.1.2 Breath Testing: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
7.2 Small Intestine Aspirate and Fluid Culture Test
- 7.2.1 Overview
- 7.2.2 Small Intestine Aspirate and Fluid Culture Test: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
7.3 Blood Test
- 7.3.1 Overview
- 7.3.2 Blood Test: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis – by Type
8.1 Hydrogen-predominant SIBO
- 8.1.1 Overview
- 8.1.2 Hydrogen-predominant SIBO: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.2 Methane-predominant SIBO
- 8.2.1 Overview
- 8.2.2 Methane-predominant SIBO: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
8.3 Recurrent SIBO
- 8.3.1 Overview
- 8.3.2 Recurrent SIBO : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Thousand)
9. North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.1.1 US: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Diagnosis
- 9.2.1.1.2 US: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Type
- 9.2.1.2 Canada:
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.2.1 Canada: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Diagnosis
- 9.2.1.2.2 Canada: North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Type
- 9.2.1.3 Mexico :
North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market – Revenue and Forecast to 2028 (US$ Thousand)
- 9.2.1.3.1 Mexico : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Diagnosis
- 9.2.1.3.2 Mexico : North America Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Breakdown, by Type
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Aerodiagnostics, LLC.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Commonwealth Diagnostics International
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DirectLabs, LLC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Genova Diagnostics
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Health Associates Medical Group
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Metabolic Solutions, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Pivotal Diagnostics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 SIBO Diagnostics
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 SIBOTest
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Vibrant Wellness
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations